this medication 750 showcases a compelling example within the biochemical pharmacy realm . Its mechanism of action fundamentally targets cyclooxygenase catalysts , specifically COX-1 , reducing the generation of inflammatory mediators . Given a biochemical analysis, Relafen's therapeutic potential copyrights on this ability to preferentially inhibi